Press releases | WebDisclosure

Basculer en Français

11277	Companies
250594	Keywords
179225	Articles
136424	Press releases

Home
Press releases

PRESS RELEASE

published on 06/01/2025 at 19:15, 1 year 5 months ago

Transgene and NEC Present Durable Disease-Free Survival and Sustained T Cell Responses at 24 Months with Individualized Cancer Vaccine TG4050
Transgene and NEC reveal positive data on TG4050 cancer vaccine, demonstrating durable disease-free survival and sustained T cell responses at 24 months in HPV-negative head and neck cancer. Conference call on June 6, 2025

Cancer Vaccine Transgene TG4050 ASCO 2025 NEC
PRESS RELEASE

published on 06/01/2025 at 10:00, 1 year 5 months ago

OPPO and the UEFA Champions League Final: Powering Football Innovation On and Off the Pitch
OPPO celebrates the conclusion of the UEFA Champions League season with football-related CSR programs and technological innovations, empowering fans and players worldwide

Technology Football CSR OPPO UEFA Champions League
PRESS RELEASE

published on 05/31/2025 at 21:00, 1 year 5 months ago

Leclanché annonce le dépôt d'une demande de prolongation du délai de publication du rapport annuel 2024 et la suspension temporaire de la cotation de ses actions nominatives à la SIX Swiss Exchange
Leclanché annonce le dépôt d'une demande de prolongation du délai de publication du rapport annuel 2024 et la suspension temporaire de la cotation de ses actions nominatives à la SIX Swiss Exchange

Leclanché Rapport Annuel Suspension Demande Prolongation
PRESS RELEASE

published on 05/31/2025 at 21:00, 1 year 5 months ago

Leclanché SA: Leclanché announces filing of request to extend the publication deadline for the 2024 Annual Report and the temporary suspension of trading of its registered shares on SIX Swiss Exchange
Leclanché announces request to extend 2024 Annual Report deadline and temporary SIX Swiss Exchange trading suspension, implements measures to strengthen financial position

SIX Swiss Exchange Leclanché Deadline Extension Financial Measures 2024 Annual Report
PRESS RELEASE

published on 05/31/2025 at 18:37, 1 year 5 months ago

Meyer Burger files for insolvency for German subsidiaries
Meyer Burger Technology AG's German subsidiaries file for insolvency as restructuring negotiations fail, seeking extension for presenting 2024 financial results

Financial Results Restructuring Insolvency Meyer Burger German Subsidiaries
PRESS RELEASE

published on 05/31/2025 at 14:50, 1 year 5 months ago

Turkiye Garanti Bankasi A.S.: Brokerage Houses Warrants Redemption Prices
Turkiye Garanti Bankasi A.S. releases brokerage houses warrants redemption prices for various assets on May 30, 2025

Investors Warrants Turkiye Garanti Bankasi Redemption Prices Brokerage Houses
PRESS RELEASE

published on 05/31/2025 at 14:46, 1 year 5 months ago

Turkiye Garanti Bankasi A.S.: CMB Approval for Bond Issuance to Foreign Markets
Turkiye Garanti Bankasi A.S. receives CMB approval for bond issuance to foreign markets under GMTN program with ISIN XS3087684810, XS3087684901, and XS3087729342 in EUR and USD

Bond Issuance Turkiye Garanti Bankasi A.S. Foreign Markets CMB Approval GMTN Program
PRESS RELEASE

published on 05/31/2025 at 14:41, 1 year 5 months ago

Turkiye Garanti Bankasi A.S.: Announcement regarding Fitch Ratings
Fitch Ratings affirms Garanti BBVA's credit ratings with Stable outlook on May 30, 2025. Viability Rating kept at bb-. Details in the announcement

Stable Outlook Garanti BBVA Credit Ratings Fitch Ratings Viability Rating
PRESS RELEASE

published on 05/31/2025 at 09:15, 1 year 5 months ago

Hong Kong-headquartered International Mediation Body Established
Establishment of International Organization for Mediation (IOMed) in Hong Kong marks a significant milestone in international mediation. More than 80 countries and 20 organizations participated in the signing ceremony

Hong Kong Médiation International Organization For Mediation International Disputes Signing Ceremony
PRESS RELEASE

published on 05/31/2025 at 06:16, 1 year 5 months ago

Moderna Receives U.S. FDA Approval for COVID-19 Vaccine mNEXSPIKE
Moderna's mNEXSPIKE, a new COVID-19 vaccine, receives FDA approval for high-risk age groups. The vaccine shows higher efficacy compared to the original mRNA-1273. Safety profile similar to Spikevax

FDA Approval COVID-19 Vaccine Moderna Efficacy MNEXSPIKE

Accesswire

Published on 11/04/2026 at 23:10, 5 hours 1 minute ago

Ur-Energy Announces Date for Third Quarter 2026 Results and Conference Call and Webcast
Published on 11/04/2026 at 23:00, 5 hours 11 minutes ago

Avino Reports Q3 2026 Financial Results
Published on 11/04/2026 at 23:00, 5 hours 11 minutes ago

Viemed Healthcare Announces Third Quarter 2026 Financial Results
Published on 11/04/2026 at 22:15, 5 hours 56 minutes ago

Zomedica Announces Record Third Quarter Revenue of $9.9 Million, Up 22% Year-Over-Year, Net Loss Reduced 48%, with $41 Million in Liquidity
Published on 11/04/2026 at 22:05, 6 hours 6 minutes ago

Stabilis Solutions Announces Third Quarter 2026 Results

View all ACCESSWIRE

EQS Group

Published on 11/05/2026 at 04:00, 11 minutes ago

Andamanda Phuket: A Must-Visit Water Park for Family Holiday
Published on 11/05/2026 at 03:55, 16 minutes ago

AlphaESS Named a BloombergNEF Tier 1 Energy Storage Manufacturer for the Fifth Consecutive Quarter in Q4 2026
Published on 11/05/2026 at 03:10, 1 hour 1 minute ago

SensAI Veritas Launches SensAI Gateway™ and SensAI Helm™: Bringing Risk Intelligence to the Moment of Trust
Published on 11/05/2026 at 00:02, 4 hours 9 minutes ago

EQS-Adhoc: NEXTDC Limited: Response to Share Raid by Goodman Group and Digital Realty
Published on 11/04/2026 at 19:41, 8 hours 30 minutes ago

EQS-Adhoc: SNP SE Raises Outlook for the Full Year 2026

Les Echos

Published on 11/04/2026 at 18:00, 10 hours 11 minutes ago

The Belgian State and Engie Group have agreed to extend the target date for concluding the Heads of Terms until 12 December 2026
Published on 11/04/2026 at 18:00, 10 hours 11 minutes ago

L’État belge et le groupe ENGIE ont convenu de se donner un délai supplémentaire jusqu’au 12 décembre 2026 pour la conclusion des Heads of Terms
Published on 11/04/2026 at 17:45, 10 hours 26 minutes ago

October 2026
Published on 11/04/2026 at 17:45, 10 hours 26 minutes ago

Octobre 2026
Published on 11/04/2026 at 17:44, 10 hours 27 minutes ago

Aéroports de Paris SA - Information regarding the voting rights and shares as of 31 October 2026

View all LES ECHOS COMFI WIRE